Comparison of the efficacy among nilotinib, dasatinib, flumatinib and imatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients: A real-world multi-center retrospective study
Article in Clinical Lymphoma Myeloma & Leukemia (February 2024)